Contemporary issues facing institutional managers, as well as P&T committee members, focus heavily on balancing patient care costs and outcomes. That balance should assist organizations in achieving their value propositions in providing optimal patient care—in this case, through the appropriate use of pharmaceutical agents. Achieving a balance requires informed decision-making along with access...
